HEALTH CARE:
A Big Fat Problem*

By Henry I. Miller

A quarter of a century after Procter & Gamble developed the fat substitute olestra, the Food and Drug Administration finally approved it. Now a group associated with Ralph Nader, the Center for Science in the Public Interest, is accusing the FDA of beinga corporate lapdog. Hoover fellow Henry I. Miller details an absurdity.

*This article is available only in the print edition of the Hoover Digest. Click here to request a free issue.

Henry I. Miller, M.S., M.D., is a research fellow at the Hoover Institution, where his research focuses on public policy toward science and technology. It encompasses a number of areas, including pharmaceutical development, the new biotechnology, models for regulatory reform, and the emergence of new viral diseases.